Table 2.
Left ventricular hypertrophy | Diastolic dysfunction | Impaired GLS (<18%) | |||||||
---|---|---|---|---|---|---|---|---|---|
R 2 | OR (95% CI) | P value | R 2 | OR (95% CI) | P value | R 2 | OR (95% CI) | P value | |
Models with each of following:a | |||||||||
Heart rate (11 bpm) | 0.083 | 0.73 (0.54, 0.99) | 0.044 | 0.181 | 1.41 (1.13, 1.76) | 0.003 | 0.136 | 1.54 (1.24, 1.91) | <0.001 |
Cornell product (635 mm · ms) | 0.101 | 1.48 (1.14, 1.90) | 0.003 | 0.175 | 1.38 (1.08, 1.78) | 0.012 | 0.116 | 1.37 (1.11, 1.69) | 0.003 |
minSTmV5V6 (39 μV) | 0.080 | 0.75 (0.55, 1.01) | 0.058 | 0.157 | 0.92 (0.74, 1.13) | 0.420 | 0.098 | 0.84 (0.68, 1.04) | 0.843 |
PTFV1 (3532 μVms) | 0.075 | 1.24 (0.94, 1.64) | 0.136 | 0.156 | 0.93 (0.75, 1.15) | 0.521 | 0.091 | 0.98 (0.79, 1.21) | 0.866 |
Model with all the following: | |||||||||
Heart rate (11 bpm) | 0.134 | 0.72 (0.53, 0.99) | 0.047 | 0.199 | 1.39 (1.10, 1.75) | 0.005 | 0.158 | 1.52 (1.22, 1.90) | <0.001 |
Cornell product (635 mm · ms) | 1.49 (1.13, 1.96) | 0.004 | 1.39 (1.05, 1.84) | 0.021 | 1.31 (1.04, 1.65) | 0.021 | |||
minSTmV5V6 (39 μV) | 0.87 (0.63, 1.19) | 0.379 | 1.02 (0.81, 1.29) | 0.872) | 0.92 (0.73, 1.16) | 0.492 | |||
PTFV1 (3532 μVms) | 1.27 (0.92, 1.67) | 0.166 | 0.98 (0.78, 1.23) | 0.853 | 1.06 (0.85, 1.33) | 0.606 |
CI, confidence interval; GLS, global longitudinal strain; minSTmV5V6, minimal ST deviation at m point of leads V5 and V6; OR, odds ratio; PTFV1, P‐wave terminal force measured at lead V1.
Each model contains age, gender, heart rate, SBP, BMI, Charlson comorbidity score; LIFE: using cut‐offs from LIFE study as stated in methods.
Value as per standard deviation.